These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 7340881)

  • 21. Human plasma vasopressin response to potent loop-diuretic drugs.
    Baylis PH; De Beer FC
    Eur J Clin Pharmacol; 1981; 20(5):343-6. PubMed ID: 7286044
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinical pharmacology of loop diuretics.
    Brater DC
    Drugs; 1991; 41 Suppl 3():14-22. PubMed ID: 1712712
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The influence of nonsteroidal anti-inflammatory drugs and probenecid on the renal response to and kinetics of piretanide in man.
    Dixey JJ; Noormohamed FH; Pawa JS; Lant AF; Brewerton DA
    Clin Pharmacol Ther; 1988 Nov; 44(5):531-9. PubMed ID: 3180634
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Acute and long-term renal and metabolic effects of piretanide in congestive cardiac failure.
    McNabb WR; Noormohamed FH; Lant AF
    Br J Clin Pharmacol; 1988 Aug; 26(2):143-54. PubMed ID: 3207551
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Differential effects of human atrial natriuretic peptide and furosemide on glomerular filtration rate and renal oxygen consumption in humans.
    Swärd K; Valsson F; Sellgren J; Ricksten SE
    Intensive Care Med; 2005 Jan; 31(1):79-85. PubMed ID: 15565364
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of furosemide, bumetanide and piretanide on the sensor of the tubuloglomerular feedback mechanism.
    Brunkhorst R; Müller-Ott K; Gutsche HU; Niedermayer W
    Proc Eur Dial Transplant Assoc; 1978; 15():613-6. PubMed ID: 740700
    [No Abstract]   [Full Text] [Related]  

  • 27. Activity of a new high efficiency diuretic in man: piretanide (HOE 118).
    Pozet N; Hadj-Aissa A; Pellet M; Traeger J
    Br J Clin Pharmacol; 1980 Jun; 9(6):577-83. PubMed ID: 7387813
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Renal pharmacodynamic effects of torasemide and furosemide in normal man.
    Dupont AG; Gerlo E; Van der Niepen P; Laekeman G; Piepsz A
    Arzneimittelforschung; 1988 Jan; 38(1A):172-5. PubMed ID: 3285829
    [TBL] [Abstract][Full Text] [Related]  

  • 29. An orally active adenosine A1 receptor antagonist, FK838, increases renal excretion and maintains glomerular filtration rate in furosemide-resistant rats.
    Schnackenberg CG; Merz E; Brooks DP
    Br J Pharmacol; 2003 Aug; 139(8):1383-8. PubMed ID: 12922924
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The effects of naproxen and sulindac on renal function and their interaction with hydrochlorothiazide and piretanide in man.
    Dixey JJ; Noormohamed FH; Lant AF; Brewerton DA
    Br J Clin Pharmacol; 1987 Jan; 23(1):55-63. PubMed ID: 3814463
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Piretanide and urinary excretion of ions in rat. Effect of indomethacin.
    Nguyen-Simonnet H; Gauthier C; Pellet M
    Clin Exp Pharmacol Physiol; 1981 Jul; 8(4):315-25. PubMed ID: 7307350
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Renal action of a novel uricosuric diuretic, S-8666. I. Clearance and tubular microinjection studies in rats.
    Shimuizu T; Nakamura M; Imai M
    J Pharmacol Exp Ther; 1988 May; 245(2):644-50. PubMed ID: 3367310
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Analysis of the natriuretic action of a loop diuretic, piretanide, in man.
    Noormohamed FH; Lant AF
    Br J Clin Pharmacol; 1991 Apr; 31(4):463-9. PubMed ID: 2049256
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pharmacokinetics of the loop diuretic piretanide in renal failure.
    Walter U; Röckel A; Lahn W; Heidland A; Heptner W
    Eur J Clin Pharmacol; 1985; 29(3):337-43. PubMed ID: 4076330
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Role of EDHF in the vasodilatory effect of loop diuretics in guinea-pig mesenteric resistance arteries.
    Pourageaud F; Bappel-Gozalbes C; Marthan R; Freslon JL
    Br J Pharmacol; 2000 Nov; 131(6):1211-9. PubMed ID: 11082130
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Furosemide accelerates gentamicin accumulation in cultured renal cells (LLC-PK1 cells).
    Nakahama H; Fukuhara Y; Orita Y; Yamauchi A; Takama T; Kamada T
    Nephron; 1989; 53(2):138-41. PubMed ID: 2812167
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Frusemide, ACE inhibition, renal dopamine and prostaglandins: acute interactions in normal man.
    MacDonald TM; Craig K; Watson ML
    Br J Clin Pharmacol; 1989 Dec; 28(6):683-94. PubMed ID: 2532921
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The influence of age on renal and extrarenal effects of frusemide.
    Andreasen F; Hansen U; Husted SE; Mogensen CE; Pedersen EB
    Br J Clin Pharmacol; 1984 Jul; 18(1):65-74. PubMed ID: 6743491
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Micropuncture study of the handling of gentamicin by the rat kidney.
    Senekjian HO; Knight TF; Weinman EJ
    Kidney Int; 1981 Mar; 19(3):416-23. PubMed ID: 7241882
    [No Abstract]   [Full Text] [Related]  

  • 40. Mathematical evaluation of the effects of tizolemide, furosemide and placebo in healthy adults.
    Leary WP; Reyes AJ
    S Afr Med J; 1982 Mar; 61(11):398-401. PubMed ID: 7064012
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.